0      0

Clostridium Difficile: An Organism with a New Virulence


‐ Jan 24, 2012 2:30pm


Credits: None available.

  1. Summarize the etiology and pathogenesis of C. Difficile infections
  2. Distinguish among selective pharmaceutical agents that predispose patients to C. Difficile colitis
  3. Define the unique risk factors for patients with inflammatory bowel disease and C. Difficile infections and their treatment challenges

Speaker(s):

Speaker(s):

Credits

Credits: None available.